These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 10083304)

  • 1. Chimeric liver established by recipient type bone marrow cell transplantation to donor before to liver transplantation produces marked suppression of allograft rejection in rats.
    Sanada O; Sumimoto R; Fukuda Y; Kaneda K; Ito H; Asahara T; Dohi K
    Transplant Proc; 1999; 31(1-2):704-6. PubMed ID: 10083304
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of donor-specific hyporeactivity in augmented microchimerism in rat liver transplantation followed by donor bone marrow.
    Tashiro H; Fukuda Y; Kimura A; Hoshino S; Shintaku S; Ohdan H; Miyata H; Dohi K
    Transplant Proc; 1997; 29(1-2):1196-7. PubMed ID: 9123269
    [No Abstract]   [Full Text] [Related]  

  • 3. Correlation of high-level microchimerism with graft acceptance in rat liver transplantation.
    Tashiro H; Fukuda Y; Kimura A; Hoshino S; Furukawa M; Shintaku S; Dohi K
    Transplant Proc; 1997; 29(1-2):1230-1. PubMed ID: 9123287
    [No Abstract]   [Full Text] [Related]  

  • 4. Establishment of chimerism in donor liver with recipient-type bone marrow cells prior to liver transplantation produces marked suppression of allograft rejection in rats.
    Sanada O; Fukuda Y; Sumimoto R; Hoshino S; Nishihara M; Kaneda K; Asahara T; Dohi K
    Transpl Int; 1998; 11 Suppl 1():S174-8. PubMed ID: 9664973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brequinar sodium suppresses liver allograft rejection and induces permanent tolerance in the rat.
    Knoop M; Cramer DV; Chapman FC; Makowka L
    Transplant Proc; 1993 Feb; 25(1 Pt 1):706-7. PubMed ID: 8438447
    [No Abstract]   [Full Text] [Related]  

  • 6. Accelerated rejection of a skin graft after liver transplantation from a sensitized donor: functional aspects of microchimerism.
    Dahmen U; Tanigawa T; Rogiers X; Lindkaer-Jensen S; Broelsch CE
    Transplant Proc; 1996 Dec; 28(6):3243-5. PubMed ID: 8962256
    [No Abstract]   [Full Text] [Related]  

  • 7. Establishment of chimerism in donors by intraportal injection of recipient-type bone marrow cells with concomitant administration of FK 506 before liver transplantation prolongs liver allograft survival in rats.
    Sanada O; Sumimoto R; Fukuda Y; Hoshino S; Nishihara M; Kaneda K; Ito H; Asahara T; Dohi K
    Transplant Proc; 1998 Nov; 30(7):3860-1. PubMed ID: 9838689
    [No Abstract]   [Full Text] [Related]  

  • 8. Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: tissue distribution of donor class I major histocompatibility complex antigen-positive cells in the recipient.
    Goto M; Yamaguchi Y; Hamaguchi H; Hisama N; Miyanari N; Ichiguchi O; Mori K; Shirakusa T; Ogawa M
    Transplant Proc; 1995 Apr; 27(2):1625-7. PubMed ID: 7725428
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlation between allograft survival and chimeric state after bone marrow infusion in rat small bowel transplantation.
    Bakonyi Neto A; Ricordi C; Feo CF; Porcu A; Misiakos EP; Gandia C; Ruiz P; Bertho M; Carreno M; Esquenazi V; Miller J; Tzakis AG
    Pediatr Transplant; 1999 Feb; 3(1):67-73. PubMed ID: 10359034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of passenger leukocyte genotype in rejection and acceptance of rat liver allografts.
    Kreisel D; Petrowsky H; Krasinskas AM; Krupnick AS; Szeto WY; McLean AD; Popma SH; Gelman AE; Traum MK; Furth EE; Moore JS; Rosengard BR
    Transplantation; 2002 May; 73(9):1501-7. PubMed ID: 12023631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimerism, graft-vs-host disease, rejection, and their association with reciprocal donor-host immune reactions after cell, organ, and composite tissue transplantation.
    Llull R; Murase N; Ye Q; Demetris AJ; Starzl TE
    Transplant Proc; 1997; 29(1-2):1203-4. PubMed ID: 9123273
    [No Abstract]   [Full Text] [Related]  

  • 12. A new immunosuppressive drug, brequinar sodium, suppresses liver allograft rejection in the rat.
    Knoop M; Cramer DV; Chapman FC; Makowka L
    Transplant Proc; 1993 Aug; 25(4):2697-8. PubMed ID: 8356719
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunomodulation of intestinal transplant with allograft irradiation and simultaneous donor bone marrow infusion.
    Murase N; Ye Q; Lee RG; Demetris AJ; Abu-Elmagd K; Reyes J; Starzl TE
    Transplant Proc; 1999; 31(1-2):565-6. PubMed ID: 10083238
    [No Abstract]   [Full Text] [Related]  

  • 14. Intrathymic inoculation of donor cells promotes survival of rat orthotopic liver allografts.
    Campos L; Alfrey EJ; Posselt AM; Odorico JS; Naji A; Barker CF
    Transplant Proc; 1993 Feb; 25(1 Pt 1):488-9. PubMed ID: 8438390
    [No Abstract]   [Full Text] [Related]  

  • 15. Contribution of passenger leukocytes to the induction and maintenance of heart allograft acceptance.
    Ko S; Deiwick A; Dinkel A; Wonigeit K; Schlitt HJ
    Transplant Proc; 1999; 31(1-2):158-9. PubMed ID: 10083056
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of graft inoculation with donor bone marrow cells on kidney allograft survival in antilymphocyte serum-treated rats.
    Otsu I; Gottschalk R; Monaco AP
    Transplant Proc; 1994 Oct; 26(5):3060. PubMed ID: 7940962
    [No Abstract]   [Full Text] [Related]  

  • 17. Small bowel transplantation in sensitized recipients: comparison with heart, kidney, and liver grafts.
    Murase N; Fujisaki S; Tanabe M; Tsamandas AC; Todo S; Starzl TE; Demetris AJ
    Transplant Proc; 1994 Jun; 26(3):1517-8. PubMed ID: 7518139
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of donor irradiation or recipient interleukin-2 treatment on survival of spontaneously accepted rat liver allografts.
    Tu Y; Arima T; Flye MW
    Transplant Proc; 1997; 29(1-2):856-7. PubMed ID: 9123554
    [No Abstract]   [Full Text] [Related]  

  • 19. Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: the distribution of donor class I-positive cells in the recipient.
    Goto M; Yamaguchi Y; Matsuno K; Takata N; Makino Y; Kikuchi N; Hamaguchi H; Hisama N; Otsuka Y; Mori K
    Transplant Proc; 1993 Apr; 25(2):1893-5. PubMed ID: 8470217
    [No Abstract]   [Full Text] [Related]  

  • 20. Intraportal injection of specific allogeneic cells can prolong neonatal intestinal free graft survival.
    Lee SK; Perez-Atayde A; Takeda T; Vacanti JP; Lund DP
    Transplant Proc; 1994 Jun; 26(3):1579-80. PubMed ID: 8030044
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.